UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Pharmacotherapy, 2004-12, Vol.24 (12), p.1793-1799

2004

Volltextzugriff (PDF)

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004, Vol.24 (12), p.1793-1799

2004

Volltextzugriff (PDF)

Aspirin resistance and genetic polymorphisms

Journal of thrombosis and thrombolysis, 2002-08, Vol.14 (1), p.51-58

2002

Volltextzugriff (PDF)

Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists

Journal of managed care pharmacy, 2007-09, Vol.13 (7), p.598-606

2007

Volltextzugriff (PDF)

CD40 ligand: a novel target in the fight against cardiovascular disease

The Annals of pharmacotherapy, 2004-09, Vol.38 (9), p.1500-1508

2004

Volltextzugriff (PDF)

A Comparative Study of Simple Auditory Reaction Time in Blind (Congenitally) and Sighted Subjects

Indian journal of psychological medicine, 2013-07, Vol.35 (3), p.273-277

2013

Volltextzugriff (PDF)

Drug-induced thrombocytopenia in the coronary care unit

Journal of thrombosis and thrombolysis, 2000-10, Vol.10 (2), p.155-167

2000

Volltextzugriff (PDF)

Effect of sensory nerve conduction studies of median and ulnar nerve: Height and body mass index

National journal of physiology, pharmacy and pharmacology, 2021, Vol.11 (6), p.1-336

2021

Volltextzugriff (PDF)

Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: Potential clinical implications

Journal of thrombosis and thrombolysis, 2003-06, Vol.15 (3), p.217-225

2003

Volltextzugriff (PDF)

Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agents

Current cardiology reports, 2003-07, Vol.5 (4), p.310-317

2003

Volltextzugriff (PDF)

Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient

American journal of health-system pharmacy, 2003-12, Vol.60 (23), p.2479-2483

2003

Volltextzugriff (PDF)

Handedness affecting sensory nerve conduction study of median and ulnar nerve

National journal of physiology, pharmacy and pharmacology, 2021, Vol.11 (10), p.1-1202

2021

Volltextzugriff (PDF)

HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein

American journal of health-system pharmacy, 2004-08, Vol.61 (16), p.1676-1681

2004

Volltextzugriff (PDF)

Impact of a pharmacist on drug costs in a coronary care unit

American journal of health-system pharmacy, 2001-03, Vol.58 (6), p.497-502

2001

Volltextzugriff (PDF)

Lepirudin-induced thrombocytopenia following subcutaneous administration

American journal of health-system pharmacy, 2009-05, Vol.66 (9), p.834-837

2009

Volltextzugriff (PDF)

Mobilization with Plerixafor (Mozobil ®)Plus G-CSF Results in Superior Day 1 Collection of CD34+ Cells Compared to Placebo Plus G-CSF: Results From Two Randomized Placebo-Controlled Trials in Patients with Multiple Myeloma or Non-Hodgkin's Lymphoma

Blood, 2009-11, Vol.114 (22), p.3224-3224

2009

Volltextzugriff (PDF)

Myocardial infarction in an adolescent taking Adderall

American journal of health-system pharmacy, 2005-07, Vol.62 (14), p.1494-1497

2005

Volltextzugriff (PDF)

Outcomes of patients with hereditary transthyretin-mediated amyloidosis with early onset V30M versus all other mutations in APOLLO, a Phase 3 study of patisiran

Revue neurologique, 2019-04, Vol.175, p.S129-S129

2019

Volltextzugriff (PDF)

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia

Leukemia & lymphoma, 2012-03, Vol.53 (3), p.435-440

2012

Volltextzugriff (PDF)

Patisiran, an Investigational RNAi Therapeutic for Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy: Results from the Phase 3 APOLLO study (CT.001)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonists in renal failure

Journal of thrombosis and thrombolysis, 2001-02, Vol.11 (1), p.39-48

2001

Volltextzugriff (PDF)

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?

Vascular health and risk management, 2006, Vol.2 (1), p.39-48

2006

Volltextzugriff (PDF)

Polymorphism induced sensitivity to warfarin: A review of the literature

Journal of thrombosis and thrombolysis, 2003-06, Vol.15 (3), p.205-212

2003

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Englisch
(36)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Aspirin resistance and genetic polymorphisms

Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists

CD40 ligand: a novel target in the fight against cardiovascular disease

A Comparative Study of Simple Auditory Reaction Time in Blind (Congenitally) and Sighted Subjects

Drug-induced thrombocytopenia in the coronary care unit

Effect of sensory nerve conduction studies of median and ulnar nerve: Height and body mass index

Effects of angiotensin converting enzyme inhibitors on thrombotic mediators: Potential clinical implications

Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agents

Evaluation of Quality of Life and Disability in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy Following Treatment with Patisiran, An Investigational RNAi Therapeutic: Results from the Phase 3 APOLLO Study (S31.003)

Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient

Handedness affecting sensory nerve conduction study of median and ulnar nerve

HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein

Impact of a pharmacist on drug costs in a coronary care unit

Lepirudin-induced thrombocytopenia following subcutaneous administration

Mobilization with Plerixafor (Mozobil ®)Plus G-CSF Results in Superior Day 1 Collection of CD34+ Cells Compared to Placebo Plus G-CSF: Results From Two Randomized Placebo-Controlled Trials in Patients with Multiple Myeloma or Non-Hodgkin's Lymphoma

Myocardial infarction in an adolescent taking Adderall

Outcomes of patients with hereditary transthyretin-mediated amyloidosis with early onset V30M versus all other mutations in APOLLO, a Phase 3 study of patisiran

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia

Patisiran, an Investigational RNAi Therapeutic for Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy: Results from the Phase 3 APOLLO study (CT.001)

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonists in renal failure

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?

Polymorphism induced sensitivity to warfarin: A review of the literature

Suchergebnisse filtern